Jounce Therapeutics, Inc. announced that Elizabeth Trehu, M.D., the company's chief medical officer, is expected to resign from her role at the company as of a date that was not determinable at the time of such disclosure.
Jounce Therapeutics, Inc.
Equities
JNCE
US4811161011
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+16.26% | 122B | |
+21.53% | 116B | |
+22.18% | 27.03B | |
-21.77% | 20.36B | |
-16.89% | 16.43B | |
-18.07% | 15.91B | |
-44.74% | 15.6B | |
+61.42% | 14.94B | |
+3.14% | 13.59B |